Table 1.
Celiac disease in patients with fatty liver
|
Ref.
|
Country
|
Patients
|
Ultrasound
|
Liver biopsy
|
AGA
|
tTG
|
EmA
|
Duodenal biopsy
|
Response with GFD
|
| Grieco et al[12], 2001 | Italy | 30 | (+) | (+) | N/A | N/A | 4 | Negative | Complete |
| Nehra et al[13], 2001 | United States | 47 | N/A | (+) | N/A | N/A | 1 | N/A | N/A |
| Bardella et al[14], 2004 | Italy | 59 | N/A | (+) | N/A | 6 | 2 | 2/6 | Partial |
| Lo Iacono et al[15] , 2005 | Italy | 121 | N/A | (+) | N/A | 20 | 4 | 4/4 | Partial |
| Rahimi et al[16], 2011 | Iran | 316 | Either/or | Either/or | N/A | 8 | 7 | 7/8 | Complete |
| Bakhshipour et al[17], 2013 | Iran | 403 | (+) | N/A | N/A | 14 | N/A | 12/14 | Partial |
| Kamal et al[18], 2018 | Egypt | 613 | (+) | (-) | N/A | 160 | 68 | 181 | Partial |
GFD: Gluten-free diet; N/A: Not available; AGA: Anti-gliadin antibody; tTG: Tissue transglutaminase antibody; EmA: Endomysial antibody; Complete response to GFD: Normalization of liver enzymes, celiac antibodies and normal abdominal ultrasound; Partial response to GFD: Normalization of liver enzymes and celiac antibodies.